Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T05:52:33.001Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroethics of Cognitive Enhancement

Published online by Cambridge University Press:  13 March 2006

Danielle C. Turner  and
Barbara J. Sahakian
Danielle C. Turner
Affiliation:
Department of Psychiatry, University of Cambridge, School of Clinical Medicine, Box 189, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK E-mail: dct23@cam.ac.uk
Barbara J. Sahakian
Affiliation:
Department of Psychiatry, University of Cambridge, School of Clinical Medicine, Box 189, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK E-mail: dct23@cam.ac.uk
Get access

Abstract

The prospect of being able to take safe and effective drugs to improve mental functioning is becoming a reality. With the potential for widespread use of cognitive enhancers by large sectors of the population, this article discusses the rationale behind the development of these drugs and how society might benefit from them. Important ethical questions and scenarios are also raised. Scientists are urged to explore the implications of their work and engage in active debate with a wide range of interested stakeholders about the ethical and moral consequences of these new technologies to ensure maximal benefit with minimal harm.

Keywords

Cognitive EnhancementEthicsHumanNeuroethicsSmart Drugs
Type
Articles
Information
BioSocieties , Volume 1 , Issue 1 , March 2006 , pp. 113 - 123
Copyright
London School of Economics and Political Science

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)